Statements
2024
DEA and HHS Extend Telemedicine Flexibilities through 2025 - November 15, 2024
Statement from Assistant Secretary for Mental Health and Substance Use Miriam Delphin-Rittmon, Ph.D. on Suicide Prevention Month and Inaugural 988 Day - September 3, 2024
Statement from Assistant Secretary for Mental Health and Substance Use Miriam Delphin-Rittmon, Ph.D. on International Overdose Awareness Day - August 28, 2024
2023
SAMHSA Applauds Expansion of Access to Medication for Opioid Use Disorder (MOUD) - January 18, 2023
2022
Statement from Assistant Secretary for Mental Health and Substance Use Miriam Delphin-Rittmon, Ph.D. on Successful Transition to 988 - July 22, 2022
Olmstead Anniversary Statement from Assistant Secretary for Mental Health and Substance Use Miriam E. Delphin-Rittmon, Ph.D. - June 22, 2022
Statement by HHS Secretary Xavier Becerra and ONDCP Director Rahul Gupta - February 9, 2022
Statement from SAMHSA Leader on FDA’s Drug Safety Alert on Buprenorphine and Risk for Tooth Decay - January 12, 2022
2021
International Overdose Awareness Day Statement from Assistant Secretary for Mental Health and Substance Use Miriam E. Delphin-Rittmon, Ph.D. - August 31, 2021
Joint Statement of Commitment to Continuing Cooperation on the National Judicial Task Force to Examine State Courts’ Response to Mental Illness - July 16, 2021
Statement on 42 CFR Part 2 Amendments Process - April 9, 2021